IMMUNITYBIO, INC. Capital Expenditures
IMMUNITYBIO, INC. (IBRX) reported Capital Expenditures of $5.29 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-04
- IMMUNITYBIO, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $3.52M, a 225.25% increase year-over-year.
- IMMUNITYBIO, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $1.78M, a 58.43% increase year-over-year.
- IMMUNITYBIO, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $903.00K, a 57.22% decline year-over-year.
- IMMUNITYBIO, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $741.00K, a 73.46% decline year-over-year.
- IMMUNITYBIO, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $3.85M, a 44.16% decline from fiscal 2024.
- IMMUNITYBIO, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $6.89M, a 77.48% decline from fiscal 2023.
- IMMUNITYBIO, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $30.58M, a 60.87% decline from fiscal 2022.
- IMMUNITYBIO, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $78.16M, a 132.88% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $5.29M 10-Q · filed 2026-08-04 | $6.20M derived: sum of 3 quarters · filed 2026-08-04 | $6.94M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $1.78M 10-Q · filed 2026-05-07 | $2.68M derived: sum of 2 quarters · filed 2026-05-07 | $3.42M derived: sum of 3 quarters · filed 2026-05-07 | $4.50M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $903.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $1.64M derived: sum of 2 quarters · filed 2026-02-23 | $2.73M derived: sum of 3 quarters · filed 2026-08-04 | $3.85M 10-K · filed 2026-02-23 | ||||
| 2025-09-30 | $741.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.82M derived: sum of 2 quarters · filed 2026-08-04 | $2.94M 10-Q · filed 2025-11-05 | $5.05M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $2.20M 10-Q · filed 2026-08-04 | $4.31M derived: sum of 3 quarters · filed 2026-08-04 | $7.11M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $1.12M 10-Q · filed 2026-05-07 | $3.23M derived: sum of 2 quarters · filed 2026-05-07 | $6.02M derived: sum of 3 quarters · filed 2026-05-07 | $6.75M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $4.90M derived: sum of 2 quarters · filed 2026-02-23 | $5.63M derived: sum of 3 quarters · filed 2026-02-23 | $6.89M 10-K · filed 2026-02-23 | ||||
| 2024-09-30 | $2.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.52M derived: sum of 2 quarters · filed 2025-11-05 | $4.78M 10-Q · filed 2025-11-05 | $12.73M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-06-30 | $724.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $1.99M 10-Q · filed 2025-08-05 | $9.94M derived: sum of 3 quarters · filed 2026-02-23 | $15.62M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-03-31 | $1.26M 10-Q · filed 2025-05-12 | $9.22M derived: sum of 2 quarters · filed 2026-02-23 | $14.89M derived: sum of 3 quarters · filed 2026-02-23 | $23.42M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2023-12-31 | $7.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $13.63M derived: sum of 2 quarters · filed 2026-02-23 | $22.16M derived: sum of 3 quarters · filed 2026-02-23 | $30.58M 10-K · filed 2026-02-23 | ||||
| 2023-09-30 | $5.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $14.20M derived: sum of 2 quarters · filed 2024-11-12 | $22.63M 10-Q · filed 2024-11-12 | $41.56M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-06-30 | $8.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $16.95M 10-Q · filed 2024-08-12 | $35.88M derived: sum of 3 quarters · filed 2025-03-03 | $51.82M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-03-31 | $8.43M 10-Q · filed 2024-05-09 | $27.36M derived: sum of 2 quarters · filed 2025-03-03 | $43.29M derived: sum of 3 quarters · filed 2025-03-03 | $59.24M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2022-12-31 | $18.93M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $34.87M derived: sum of 2 quarters · filed 2025-03-03 | $50.81M derived: sum of 3 quarters · filed 2025-03-03 | $78.16M 10-K · filed 2025-03-03 | ||||
| 2022-09-30 | $15.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $31.88M derived: sum of 2 quarters · filed 2023-11-09 | $59.23M 10-Q · filed 2023-11-09 | $69.63M derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2022-06-30 | $15.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $43.30M 10-Q · filed 2023-08-08 | $53.70M derived: sum of 3 quarters · filed 2024-03-19 | $61.73M derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2022-03-31 | $27.35M 10-Q · filed 2023-05-11 | $37.75M derived: sum of 2 quarters · filed 2024-03-19 | $45.78M derived: sum of 3 quarters · filed 2024-03-19 | $53.83M derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2021-12-31 | $10.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $18.43M derived: sum of 2 quarters · filed 2024-03-19 | $26.48M derived: sum of 3 quarters · filed 2024-03-19 | $33.56M 10-K · filed 2024-03-19 | ||||
| 2021-09-30 | $8.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $16.08M derived: sum of 2 quarters · filed 2022-11-09 | $23.16M 10-Q · filed 2022-11-09 | $22.46M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | $8.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $15.13M 10-Q · filed 2022-08-08 | $14.43M derived: sum of 3 quarters · filed 2023-03-01 | $16.47M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | $7.08M 10-Q · filed 2022-05-10 | $6.38M derived: sum of 2 quarters · filed 2023-03-01 | $8.43M derived: sum of 3 quarters · filed 2023-03-01 | $8.44M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | -$699.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.34M derived: sum of 2 quarters · filed 2023-03-01 | $1.35M derived: sum of 3 quarters · filed 2023-03-01 | $1.67M 10-K · filed 2023-03-01 | $2.64M 10-K · filed 2021-03-04 | |||
| 2020-09-30 | $2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $2.05M derived: sum of 2 quarters · filed 2021-11-12 | $2.37M 10-Q · filed 2021-11-12 | $2.24M 10-Q · filed 2020-11-09 | $3.15M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $324.00K 10-Q · filed 2021-08-12 | $540.00K 10-Q · filed 2020-08-07 | $1.11M derived: sum of 3 quarters · filed 2022-03-01 | $1.52M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | $315.00K 10-Q · filed 2021-05-14 | $146.00K 10-Q · filed 2020-05-11 | $1.10M derived: sum of 2 quarters · filed 2022-03-01 | $1.51M derived: sum of 3 quarters · filed 2022-03-01 | $2.50M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | $785.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.20M derived: sum of 2 quarters · filed 2022-03-01 | $2.18M derived: sum of 3 quarters · filed 2022-03-01 | $4.29M 10-K · filed 2022-03-01 | $4.18M 10-K · filed 2020-03-25 | |||
| 2019-09-30 | $413.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $1.40M derived: sum of 2 quarters · filed 2020-11-09 | $3.50M 10-Q · filed 2020-11-09 | $5.55M derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2019-06-30 | $985.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $3.09M 10-Q · filed 2020-08-07 | $5.13M derived: sum of 3 quarters · filed 2021-03-04 | $8.80M derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2019-03-31 | $2.10M 10-Q · filed 2020-05-11 | $4.15M derived: sum of 2 quarters · filed 2021-03-04 | $7.81M derived: sum of 3 quarters · filed 2021-03-04 | $10.30M derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2018-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $5.71M derived: sum of 2 quarters · filed 2021-03-04 | $8.20M derived: sum of 3 quarters · filed 2021-03-04 | $13.10M 10-K · filed 2021-03-04 | ||||
| 2018-09-30 | $3.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $6.16M derived: sum of 2 quarters · filed 2019-11-05 | $11.06M 10-Q · filed 2019-11-05 | $22.49M derived: sum of 4 quarters · filed 2020-03-25 | ||||
| 2018-06-30 | $2.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $7.39M 10-Q · filed 2019-08-06 | $18.83M derived: sum of 3 quarters · filed 2020-03-25 | $29.54M derived: sum of 4 quarters · filed 2020-03-25 | ||||
| 2018-03-31 | $4.90M 10-Q · filed 2019-05-08 | $16.34M derived: sum of 2 quarters · filed 2020-03-25 | $27.05M derived: sum of 3 quarters · filed 2020-03-25 | $35.21M derived: sum of 4 quarters · filed 2020-03-25 | ||||
| 2017-12-31 | $11.43M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $22.15M derived: sum of 2 quarters · filed 2020-03-25 | $30.31M derived: sum of 3 quarters · filed 2020-03-25 | $34.81M 10-K · filed 2020-03-25 | ||||
| 2017-09-30 | $10.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $18.87M derived: sum of 2 quarters · filed 2018-11-07 | $23.38M 10-Q · filed 2018-11-07 | $24.74M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-06-30 | $8.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $12.66M 10-Q · filed 2018-08-06 | $14.02M derived: sum of 3 quarters · filed 2019-03-13 | $17.10M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-03-31 | $4.51M 10-Q · filed 2018-05-07 | $5.87M derived: sum of 2 quarters · filed 2019-03-13 | $8.95M derived: sum of 3 quarters · filed 2019-03-13 | $10.00M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2016-12-31 | $1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $4.44M derived: sum of 2 quarters · filed 2019-03-13 | $5.49M derived: sum of 3 quarters · filed 2019-03-13 | $6.56M 10-K · filed 2019-03-13 | ||||
| 2016-09-30 | $3.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $4.13M derived: sum of 2 quarters · filed 2017-11-07 | $5.20M 10-Q · filed 2017-11-07 | $6.16M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $2.12M 10-Q · filed 2017-08-07 | $3.08M derived: sum of 3 quarters · filed 2018-03-12 | $4.21M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-03-31 | $1.07M 10-Q · filed 2017-05-08 | $2.02M derived: sum of 2 quarters · filed 2018-03-12 | $3.16M derived: sum of 3 quarters · filed 2018-03-12 | $3.27M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2015-12-31 | $955.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $2.09M derived: sum of 2 quarters · filed 2018-03-12 | $2.20M derived: sum of 3 quarters · filed 2018-03-12 | $2.24M 10-K · filed 2018-03-12 | ||||
| 2015-09-30 | $1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $1.25M derived: sum of 2 quarters · filed 2016-11-10 | $1.29M 10-Q · filed 2016-11-10 | $1.32M derived: sum of 4 quarters · filed 2017-03-15 | ||||
| 2015-06-30 | $114.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $152.00K 10-Q · filed 2016-08-15 | $189.00K derived: sum of 3 quarters · filed 2017-03-15 | $370.00K derived: sum of 4 quarters · filed 2017-03-15 | ||||
| 2015-03-31 | $38.00K 10-Q · filed 2016-05-16 | $75.00K derived: sum of 2 quarters · filed 2017-03-15 | $256.00K derived: sum of 3 quarters · filed 2017-03-15 | |||||
| 2014-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $218.00K derived: sum of 2 quarters · filed 2017-03-15 | $235.00K 10-K · filed 2017-03-15 | |||||
| 2014-09-30 | $181.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $198.00K 10-Q · filed 2015-11-12 | ||||||
| 2014-06-30 | $17.00K 10-Q · filed 2015-09-10 | |||||||
| 2013-12-31 | $3.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |